Patent US4643715A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4643715A Expired / Lapsed US ⏱️ 0.0 years remaining

Artificial organ and method for manufacture thereof

Assignee: Asahi Kasei Medical Co Ltd
•
Filing: 1986-06-24
•
Granted: 1987-02-17
•
Expires: 2006-06-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Medical permeating membranes in a zone through which a body fluid flows, said membranes having lateral surfaces in said zone, comprising permeable membranes of regenerated cellulose and a film of a fat-soluble vitamin and glycerin on said lateral surfaces of said membranes in said zone for flow of body fluid.

Inventors

  • 👤 Keinosuke Isono
  • 👤 Keiji Naoi

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 06:36
CPC Classifications
B; B01; B01D; B01D67/00; B01D67/0081; B01D67/0088; B01D63/00; B01D63/02; B01D63/021; B01D63/0233; B01D65/00; B01D65/02; B01D65/022; B01D2321/00; B01D2321/32

Claims Analysis

Total Claims: 14
Claim 1
Independent Claim 54 words
Medical permeating membranes at least portions of which are adopted to be in a zone through which a body fluid flows, said membranes having lateral surfaces adopted to be in said zone, comprising permeable membranes of regenerated cellulose and a film of a fat-soluble vitamin and glycerin on said lateral surfaces of said membranes.
Claim 2
Dependent Claim 54 words
Medical permeating membranes at least portions of which are adopted to be in a zone through which a body fluid flows, said membranes having lateral surfaces adopted to be in said zone, comprising permeable membranes of regenerated cellulose and a film of a fat-soluble vitamin and glycerin on said lateral surfaces of said membranes.
Claim 3
Dependent Claim 54 words
The medical permeating membranes according to claim 1, wherein said film contains said fat-soluble vitamin in an amount of not less than 0.1 mg per m 2 of said permeable membranes of regenerated cellulose and glycerin in an amount of at least 0.5% based on the weight of said permeable membranes of regenerated cellulose.
Claim 4
Dependent Claim 33 words
The medical permeating membranes according to claim 2, wherein said fat-soluble vitamin is at least one member selected from the group consisting of vitamin A, vitamin D, vitamin E, vitamin K and uviquinone.
Claim 5
Dependent Claim 20 words
The medical permeating membranes according to claim 1, wherein said permeable membranes of regenerated cellulose are hollow fiber type membranes.
Claim 6
Dependent Claim 33 words
The medical permeating membranes according to claim 2, wherein said fat-soluble vitamin is at least one member selected from the group consisting of vitamin A, vitamin D, vitamin E, vitamin K and uviquinone.
Claim 7
Dependent Claim 20 words
The medical permeating membranes according to claim 5, wherein said permeable membranes of regenerated cellulose are hollow fiber type membranes.
Claim 8
Dependent Claim 20 words
The medical permeating membranes according to claim 2, wherein said permeable membranes of regenerated cellulose are hollow fiber type membranes.
Claim 9
Dependent Claim 20 words
The medical permeating membranes according to claim 3, wherein said permeable membranes of regenerated cellulose are hollow fiber type membranes.
Claim 10
Dependent Claim 15 words
The medical permeating membranes according to claim 6, wherein said fat-soluble vitamin is vitamin A.
Claim 11
Dependent Claim 15 words
The medical permeating membranes according to claim 6, wherein said fat-soluble vitamin is vitamin D.
Claim 12
Dependent Claim 15 words
The medical permeating membranes according to claim 6, wherein said fat-soluble vitamin is vitamin E.
Claim 13
Dependent Claim 15 words
The medical permeating membranes according to claim 6, wherein said fat-soluble vitamin is vitamin K.
Claim 14
Dependent Claim 14 words
The medical permeating membranes according to claim 6, wherein said fat-soluble vitamin is uviquinone.

References Cited (Backward Citations)

US4211602A Cited
US4354933A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1990-02-16 1990-08-18 1991-02-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1994-02-16 1994-08-18 1995-02-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1998-02-16 1998-08-18 1999-02-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag